China Fortune Way Company (Sinopharm Group)

SINOPHARM GROUP :

1. China National Pharmaceutical Group Corporation

• State-owned Key Enterprise
• China’s largest, most comprehensive, and most competitive healthcare group.
• 10 subsidiaries： Sinopharm Holding, China National Biotech, Sinopharm International, Reed Sinopharm Exhibition, China National Pharmaceutical Industry, China Institute of Pharmaceutical Industry, China National Scientific Instruments and Materials, Sino-TCM, Sinopharm Engineering.
• 6 listed companies：Sinopharm Group Co., Ltd., China National Medicines Co., Ltd., Sinopharm Accord Medicines Co., Ltd., Beijing Tiantan Biological Products Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd. and China Traditional Chinese Medicine Co. Ltd.
• 300 billion yuan sales revenue in 2016
• 199 in the Fortune 2017 Global 500, the only Chinese health company in the list.

2.China Sinopharm International Corporation

• A Sinopharm wholly-owned subsidiary on international medical business and health management.
• 17.187 billion yuan sales revenue in 2016

International Operation

We have been actively developing global market on initiatives such as Belt and Road, China-Africa Cooperation, and China-Latin America Cooperation. Our business covers more than 120 countries and regions. We provide localized and quality products and services with our branch offices in India, Vietnam, Ecuador, Japan, Ghana, Egypt, UAE, and Hong Kong.

Jika terdapat kesalahan pada profile perusahaan ini silahkan laporkan ke [email protected]